Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:644-650
Published online before print January 31, 2008, doi: 10.1161/ATVBAHA.107.160044
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/4/644    most recent
ATVBAHA.107.160044v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zemani, F.
Right arrow Articles by Boisson-Vidal, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zemani, F.
Right arrow Articles by Boisson-Vidal, C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stem Cells
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:644.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Ex Vivo Priming of Endothelial Progenitor Cells With SDF-1 Before Transplantation Could Increase Their Proangiogenic Potential

Faouzia Zemani; Jean-Sébastien Silvestre; Françoise Fauvel-Lafeve; Arlette Bruel; José Vilar; Ivan Bieche; Ingrid Laurendeau; Isabelle Galy-Fauroux; Anne Marie Fischer; Catherine Boisson-Vidal

From INSERM U765 (F.Z., I.G.-F., A.M.F., C.B.-V.); INSERM U689 (J.-S.S., J.V.), Cardiovascular Research Center; INSERM U553 (F.F.-L., A.B.); Université Paris Denis Diderot (J.-S.S., F.F.-L., A.B., J.V.); INSERM U745 (I.B., I.L.), Laboratoire de Génétique Moléculaire; Université Paris Descartes (I.B., I.L., I.G.-F., A.M.F.), Faculté de Médecine; IFR 105 (F.F.-L., A.B.), Institut d’Hématologie; AP-HP (A.M.F.), Hôpital Européen Georges Pompidou, Service d’Hématologie Biologique, Paris, France.

Correspondence to Dr Catherine Boisson-Vidal, INSERM U765, Faculté de Pharmacie 4 av. de l’Observatoire, 75270 Paris, France. E-mail catherine.boisson-vidal{at}univ-paris5.fr

Objectives— As SDF-1 and its cognate receptor CXCR4 play a key role in the survival and mobilization of immature cells, we examined whether preconditioning of endothelial progenitor cells (EPCs) with SDF-1 could further promote their capacity to enhance angiogenesis.

Methods and Results— EPC exposure to 100 ng/mL SDF-1 for 30 min induced a proangiogenic phenotype, with cell migration and differentiation into vascular cords in Matrigel and increased their therapeutic potential in a nude mouse model of hindlimb ischemia. This pretreatment enhanced EPC adhesion to activated endothelium in physiological conditions of blood flow by stimulating integrin-mediated EPCs binding to endothelial cells. Pretreated EPCs showed significantly upregulated surface {alpha}4 and {alpha}M integrin subunit expression involved in the homing of immature cells to a neovasculature and enhanced FGF-2 and promatrix metalloproteinase (MMP)-2 secretion. All these effects were significantly attenuated by EPC incubation with AMD-3100, a CXCR4 antagonist, by prior HSPGs disruption and by HUVEC incubation with anti–intercellular adhesion molecule1 (ICAM-1) and anti–vascular cell adhesion molecule (VCAM) blocking antibodies. Pretreated EPCs adhered very rapidly (within minutes) and were resistant to shear stresses of up to 2500s–1.

Conclusions— SDF-1 pretreatment during EPC expansion stimulates EPC adhesion to endothelial cells and thus augments the efficiency of cell therapy for ischemic vascular diseases.

EPC exposure to SDF-1 for 30 min induced a proangiogenic phenotype, enhancing not only the ability of these cells to adhere to activated endothelium but also promoting tube formation, via integrin-, CXCR4-, and HSPGs-dependent mechanisms. Subsequently, SDF-1–treated EPCs displayed a marked therapeutic potential in a model of mice hindlimb ischemia.


Key Words: endothelial progenitor cells • SDF-1 • ischemia • HSPGs • adhesion


Related Article:

"Priming" Endothelial Progenitor Cells: A New Strategy to Improve Cell Based Therapeutics
Geoffrey C. Gurtner and Edwin Chang
Arterioscler Thromb Vasc Biol 2008 28: 1034-1035. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
C. Dunois-Larde, C. Capron, S. Fichelson, T. Bauer, E. Cramer-Borde, and D. Baruch
Exposure of human megakaryocytes to high shear rates accelerates platelet production
Blood, August 27, 2009; 114(9): 1875 - 1883.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
I. M. Packham, C. Gray, P. R. Heath, P. G. Hellewell, P. W. Ingham, D. C. Crossman, M. Milo, and T. J. A. Chico
Microarray profiling reveals CXCR4a is downregulated by blood flow in vivo and mediates collateral formation in zebrafish embryos
Physiol Genomics, August 7, 2009; 38(3): 319 - 327.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Zhao, D. Zhang, R. W. Millard, M. Ashraf, and Y. Wang
Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1{alpha} delivery and endogenous cytokine signaling
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H976 - H986.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. C. Gurtner and E. Chang
"Priming" Endothelial Progenitor Cells: A New Strategy to Improve Cell Based Therapeutics
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1034 - 1035.
[Full Text] [PDF]